Myriad Genetics (MYGN) continues to empower parents with increased access to prenatal testing. SneakPeek is now available over the counter in more than 8,800 retail locations nationwide. The product is the first of its kind to be sold on shelf in Walmart (WMT) stores greatly expanding access for expectant parents who want to learn if they’re having a girl or boy at-home as early as six weeks into pregnancy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN:
- Myriad Genetics price target lowered to $24 from $30 at Piper Sandler
- Myriad Genetics Reports Solid Q3 2024 Growth Amid Challenges
- Myriad Genetics price target lowered to $20 from $30 at TD Cowen
- Myriad Genetics reports Q3 adjusted EPS 6c, consensus 2c
- Myriad Genetics comments on UnitedHealthcare’s updated policy